Kenneth Bate's Net Worth
$10.2 Million
Who is Kenneth Bate?
Kenneth Bate has an estimated net worth of $10.2 Million. This is based on reported shares across multiple companies, which include MADRIGAL PHARMACEUTICALS, INC., Coley Pharmaceutical Group, Inc., BIOMARIN PHARMACEUTICAL INC, Vanda Pharmaceuticals Inc., AVEO PHARMACEUTICALS INC, GENOCEA BIOSCIENCES, INC., Astria Therapeutics, Inc., Epizyme, Inc., CUBIST PHARMACEUTICALS INC, NITROMED INC, and MILLENNIUM PHARMACEUTICALS INC.
SEC CIK
Kenneth Bate's CIK is 0001210238
Past Insider Trading and Trends
2013 was Kenneth Bate's most active year for acquiring shares with 10 total transactions. Kenneth Bate's most active month to acquire stocks was the month of May. 2024 was Kenneth Bate's most active year for disposing of shares, totalling 21 transactions. Kenneth Bate's most active month to dispose stocks was the month of December. 2024 saw Kenneth Bate paying a total of $2,411,344.12 for 48,408 shares, this is the most they've acquired in one year. In 2024 Kenneth Bate cashed out on 64,978 shares for a total of $8,214,998.18, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
MADRIGAL PHARMACEUTICALS, INC. (MDGL) Snapshot price: $243.89
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +59.60% | 714 |
—
|
—
| 1.91K |
Jun 25
| |||
Form 4
|
—
|
0
|
$163.54 | -$5,803,654.06 | 1.2K |
Scheduled
|
Apr 1 - Apr 2
| ||
Form 4
|
∞
| 1.2K |
—
|
—
| 1.2K |
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jul 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Coley Pharmaceutical Group, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BIOMARIN PHARMACEUTICAL INC (BMRN) Snapshot price: $83.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +10.21% | 1.1K |
—
|
—
| 11.88K |
Jun 10
| |||
Form 4
| +24.21% | 2.1K |
—
|
—
| 10.78K |
Jun 4
| |||
Form 4
| +64.45% | 3.4K |
—
|
—
| 8.68K |
May 15
| |||
Form 4
| +181.33% | 3.4K |
—
|
—
| 5.28K |
May 8
| |||
Form 4
|
∞
| 1.88K |
—
|
—
| 1.88K |
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vanda Pharmaceuticals Inc. (VNDA) Snapshot price: $5.12
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 5K |
—
|
—
| 5K |
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AVEO PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -50.00% | -375.00 |
$15.00 | -$5,625.00 | 375 |
Jan 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||